Related references
Note: Only part of the references are listed.The roles of mitochondrial dynamics and NLRP3 inflammasomes in the pathogenesis of retinal light damage
Rong Rong et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2022)
The Port Delivery System with ranibizumab-journey of mitigating vitreous hemorrhage
Ashish Sharma et al.
EYE (2022)
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
Jeffrey S. Heier et al.
LANCET (2022)
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration A Randomized Pivotal Phase 2/3 Trial
Glenn J. Jaffe et al.
OPHTHALMOLOGY (2021)
Sialylation acts as a checkpoint for innate immune responses in the central nervous system
Christine Klaus et al.
GLIA (2021)
Impact of Baseline Characteristics on Geographic Atrophy Progression in the FILLY Trial Evaluating the Complement C3 Inhibitor Pegcetacoplan
Nathan C. Steinle et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
The complement system in age-related macular degeneration
Angela Armento et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model
Soo-Young Kim et al.
EXPERIMENTAL EYE RESEARCH (2021)
Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy
Charles C. Wykoff et al.
OPHTHALMOLOGY (2021)
Targeting sialylation to treat central nervous system diseases
Jan D. Lunemann et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2021)
One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration
Amir H. Kashani et al.
TRANSLATIONAL VISION SCIENCE & TECHNOLOGY (2021)
Phase 1 Study of the Anti-HtrA1 Antibody-binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-related Macular Degeneration
Arshad M. Khanani et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2021)
Low molecular weight polysialic acid prevents lipopolysaccharide-induced inflammatory dopaminergic neurodegeneration in humanized SIGLEC11 transgenic mice
Huan Liao et al.
GLIA (2021)
Complement Factor D as a Strategic Target for Regulating the Alternative Complement Pathway
Jonathan Barratt et al.
FRONTIERS IN IMMUNOLOGY (2021)
Predicting Incremental and Future Visual Change in Neovascular Age-Related Macular Degeneration Using Deep Learning
Dun Jack Fu et al.
OPHTHALMOLOGY RETINA (2021)
KSI-301: antibody biopolymer conjugate in retinal disorders
Priya R. Chandrasekaran et al.
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY (2021)
Brolucizumab-Associated Intraocular Inflammation in Eyes Without Retinal Vasculitis
Andre J. Witkin et al.
JOURNAL OF VITREORETINAL DISEASES (2021)
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
Pravin U. Dugel et al.
OPHTHALMOLOGY (2020)
Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
Heinz Laeubli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
Activated microglia desialylate their surface, stimulating complement receptor 3-mediated phagocytosis of neurons
David H. Allendorf et al.
GLIA (2020)
Reduced sialylation triggers homeostatic synapse and neuronal loss in middle-aged mice
Christine Klaus et al.
NEUROBIOLOGY OF AGING (2020)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2020)
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Caroline R. Baumal et al.
OPHTHALMOLOGY (2020)
Control of Innate Immunity by Sialic Acids in the Nervous Tissue
Huan Liao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Microglia versus Monocytes: Distinct Roles in Degenerative Diseases of the Retina
Chen Yu et al.
TRENDS IN NEUROSCIENCES (2020)
Multimodal Evaluation of Visual Function in Geographic Atrophy versus Normal Eyes
Noemi Burguera-Gimenez et al.
CLINICAL OPHTHALMOLOGY (2020)
Geographic Atrophy: Confocal Scanning Laser Ophthalmoscopy, Histology, and Inflammation in the Region of Expanding Lesions
Vera L. Bonilha et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2020)
Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration Phase 2b Study
Jeffrey S. Heier et al.
OPHTHALMOLOGY RETINA (2020)
Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study
Kun Liu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
Patients with a fast progression profile in geographic atrophy have increased CD200 expression on circulating monocytes
Marie Krogh Nielsen et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2019)
Association of CD11b+ Monocytes and Anti-Vascular Endothelial Growth Factor Injections in Treatment of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
Yousif Subhi et al.
JAMA OPHTHALMOLOGY (2019)
The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration Results from the Randomized Phase 2 Ladder Clinical Trial
Peter A. Campochiaro et al.
OPHTHALMOLOGY (2019)
Targeting connexin hemichannels to control the inflammasome: the correlation between connexin43 and NLRP3 expression in chronic eye disease
Odunayo O. Mugisho et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Plasma markers of chronic low-grade inflammation in polypoidal choroidal vasculopathy and neovascular age-related macular degeneration
Yousif Subhi et al.
ACTA OPHTHALMOLOGICA (2019)
Polypoidal Choroidal Vasculopathy Associate With Diminished Regulatory T Cells That Are Polarized Into a T Helper 2-Like Phenotype
Yousif Subhi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Systemic Levels of Interleukin-6 Correlate With Progression Rate of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Marie Krogh Nielsen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2019)
Pharmacotherapy of retinal disease with visual cycle modulators
Rehan M. Hussain et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis
Sonia Sanz Munoz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Disrupted cholesterol metabolism promotes age-related photoreceptor neurodegeneration
Norimitsu Ban et al.
JOURNAL OF LIPID RESEARCH (2018)
N-Terminomics identifies HtrA1 cleavage of thrombospondin-1 with generation of a proangiogenic fragment in the polarized retinal pigment epithelial cell model of age-related macular degeneration
Chia-yi Chen et al.
MATRIX BIOLOGY (2018)
Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Clinical Trial
Philip J. Rosenfeld et al.
OPHTHALMOLOGY (2018)
The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Monika Fleckenstein et al.
OPHTHALMOLOGY (2018)
Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Chroma and Spectri Phase 3 Randomized Clinical Trials
Frank G. Holz et al.
JAMA OPHTHALMOLOGY (2018)
Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration
Haihan Jiao et al.
MOLECULAR NEURODEGENERATION (2018)
Treatment of Geographic Atrophy with Intravitreal Sirolimus The Age-Related Eye Disease Study 2 Ancillary Study
Gary Gensler et al.
OPHTHALMOLOGY RETINA (2018)
Impaired monocyte cholesterol clearance initiates age-related retinal degeneration and vision loss
Norimitsu Ban et al.
JCI INSIGHT (2018)
Retinal Structure in Pre-Clinical Age-Related Macular Degeneration
S. Nusinowitz et al.
CURRENT EYE RESEARCH (2018)
Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization
Juha Song et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2018)
Complement factor H in host defense and immune evasion
Raffaella Parente et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Polysialic acid blocks mononuclear phagocyte reactivity, inhibits complement activation, and protects from vascular damage in the retina
Marcus Karlstetter et al.
EMBO MOLECULAR MEDICINE (2017)
Polysialic Acid for Immunomodulation in an Animal Model for Wet Age-Related Macular Degeneration (AMD)
Thomas Langmann et al.
KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE (2017)
The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD
Sayantan Datta et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2017)
Zinc Modulates Endotoxin-Induced Human Macrophage Inflammation through ZIP8 Induction and C/EBPβ Inhibition
Charlie J. Pyle et al.
PLOS ONE (2017)
Phase I Trial of Anti-Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration
Usha Chakravarthy et al.
OPHTHALMOLOGY RETINA (2017)
Experience With a Subretinal Cell-based GossMark Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration
Allen C. Ho et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)
Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome
Satu Hyvarinen et al.
BLOOD (2016)
IBI302, a promising candidate for AMD treatment, targeting both the VEGF and complement system with high binding affinity in vitro and effective targeting of the ocular tissue in healthy rhesus monkeys
Xinyi Ren et al.
EXPERIMENTAL EYE RESEARCH (2016)
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration The Comparison of Age-Related Macular Degeneration Treatments Trials
Maureen G. Maguire et al.
OPHTHALMOLOGY (2016)
Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration
Cynthia Owsley et al.
OPHTHALMOLOGY (2016)
Macrophage polarization in experimental and clinical choroidal neovascularization
Yu Yang et al.
SCIENTIFIC REPORTS (2016)
Macrophage activation and its role in repair and pathology after spinal cord injury
John C. Gensel et al.
BRAIN RESEARCH (2015)
Receptor-Mediated Mechanism Controlling Tissue Levels of Bioactive Lipid Oxidation Products
Young-Woong Kim et al.
CIRCULATION RESEARCH (2015)
Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles
Karita Haapasalo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Complement activation and choriocapillaris loss in early AMD: Implications for pathophysiology and therapy
S. Scott Whitmore et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2015)
NLRP3 Inflammasome and Pathobiology in AMD
Lucia Celkova et al.
JOURNAL OF CLINICAL MEDICINE (2015)
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis
Martin K. Schmid et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2015)
Reactive Gliosis and the Multicellular Response to CNS Damage and Disease
Joshua E. Burda et al.
NEURON (2014)
Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration
Zohar Yehoshua et al.
OPHTHALMOLOGY (2014)
The Oxidative Stress Product Carboxyethylpyrrole Potentiates TLR2/TLR1 Inflammatory Signaling in Macrophages
Ali M. Saeed et al.
PLOS ONE (2014)
Reduced Fluorescein Angiography and Fundus Photography Use in the Management of Neovascular Macular Degeneration and Macular Edema During the Past Decade
Eric W. Schneider et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2014)
Phenotypic Transitions of Macrophages Orchestrate Tissue Repair
Margaret L. Novak et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Functional Anatomy of Complement Factor H
Elisavet Makou et al.
BIOCHEMISTRY (2013)
Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair
Maciej Lech et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling
Christopher James Ferrante et al.
INFLAMMATION (2013)
Tissue-Specific Host Recognition by Complement Factor H Is Mediated by Differential Activities of Its Glycosaminoglycan-Binding Regions
Simon J. Clark et al.
JOURNAL OF IMMUNOLOGY (2013)
Macrophage phenotypes during tissue repair
Margaret L. Novak et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
A2E accumulation influences retinal microglial activation and complement regulation
Wenxin Ma et al.
NEUROBIOLOGY OF AGING (2013)
Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
Gui-shuang Ying et al.
OPHTHALMOLOGY (2013)
INVESTIGATION OF ORAL FENRETINIDE FOR TREATMENT OF GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION
Nathan L. Mata et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)
Disclosure of the Culprits: Macrophages-Versatile Regulators of Wound Healing
Anca Sindrilaru et al.
ADVANCES IN WOUND CARE (2013)
A1120, a Nonretinoid RBP4 Antagonist, Inhibits Formation of Cytotoxic Bisretinoids in the Animal Model of Enhanced Retinal Lipofuscinogenesis
Nicoleta Dobri et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Prospective Assessment of Genetic Effects on Progression to Different Stages of Age-Related Macular Degeneration Using Multistate Markov Models
Yi Yu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Evaluation of New and Established Age-Related Macular Degeneration Susceptibility Genes in the Women's Health Initiative Sight Exam (WHI-SE) Study
Inga Peter et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Discovery of Carboxyethylpyrroles (CEPs): Critical Insights into AMD, Autism, Cancer, and Wound Healing from Basic Research on the Chemistry of Oxidized Phospholipids
Robert G. Salomon et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
C20-D3-vitamin A Slows Lipofuscin Accumulation and Electrophysiological Retinal Degeneration in a Mouse Model of Stargardt Disease
Li Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice
Anca Sindrilaru et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis
Dick Terwel et al.
JOURNAL OF NEUROSCIENCE (2011)
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
David Weismann et al.
NATURE (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Macrophage polarization in the maculae of age-related macular degeneration: A pilot study
Xiaoguang Cao et al.
PATHOLOGY INTERNATIONAL (2011)
Identification of Novel Substrates for the Serine Protease HTRA1 in the Human RPE Secretome
Eunkyung An et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up
Ciro Costagliola et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators
Jin Wu et al.
NATURE IMMUNOLOGY (2009)
Prediction Model for Prevalence and Incidence of Advanced Age-Related Macular Degeneration Based on Genetic, Demographic, and Environmental Variables
Johanna M. Seddon et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration
Michael L. Klein et al.
OPHTHALMOLOGY (2008)
Ranibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR results
Peter K. Kaiser et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Biochemical analysis of a common human polymorphism associated with age-related macular degeneration
Jiamei Yu et al.
BIOCHEMISTRY (2007)
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration
Johanna M. Seddon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration
Johanna M. Seddon et al.
HUMAN HEREDITY (2006)
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
A Nimmerjahn et al.
SCIENCE (2005)
Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration
XR Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Macrophage depletion inhibits experimental choroidal neovascularization
E Sakurai et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
The Rapamune era of immunosuppression 2003: The journey from the laboratory to clinical transplantation
J Camardo
TRANSPLANTATION PROCEEDINGS (2003)
Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
JW Crabb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8
A Kassoff et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease
RF Mullins et al.
FASEB JOURNAL (2000)
Share Paper
